Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:25 AM UTC
| NCT Number | NCT06564038 |
| Recruiting Status | Recruiting |
| Condition | B-cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 408 participants |
| Active Locations | 13 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 18, 2026: Clinical trial NCT06564038 is currently recruiting participants. This phase1 study for b-cell lymphoma is actively seeking new participants at 13 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06564038 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06564038 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.